This week we should have the Quarterly and the "Q&A" style presentation.
They normally give some subtle hints in the Quarterly as to what is going on, but nothing too revealing to put at risk any potential deal.
Hopefully they take on board shareholder comments and take the "Q&A" style presentation as a chance to sell the benefits of the bruette and autoflush products as well as the sheer size of their potential target market, just as WiseOwl did in the abovementioned research report.
- Forums
- ASX - By Stock
- ALT
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders , page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online